Gilead Pays Tribute to Patient Advocacy Work: Cara’s Story
NORTHAMPTON, MA / ACCESSWIRE / January 10, 2024 / Gilead Sciences:When employees at Gilead's recently opened New Jersey office need...
News
Nemysis Limited Signs With Kolinpharma SpA an IHAT Sales and Marketing Agreement
DUBLIN, IRELAND / ACCESSWIRE / January 10, 2024 / Nemysis Ltd and Kolinpharma® SpA ("Kolinpharma®") are pleased to announce they...
AlayaCare Releases Predictions for Home-Based Care in 2024: Transformative Trends Unveiled
TORONTO, ON / ACCESSWIRE / January 10, 2024 / In a comprehensive analysis of the future of home-based care in...
TOCCA Life Projecting Continued Company Growth and Sights Market Research Study Forecasting Industry 11.4% CAGR
WINTER PARK, FL / ACCESSWIRE / January 10, 2024 / TOCCA Life Holdings, Inc. (OTC PINK:TLIF) ("Tocca Life" or the...
MilliporeSigma’s Global Food Drive Provides 535,685 Meals
NORTHAMPTON, MA / ACCESSWIRE / January 10, 2024 / Employees from the Life Science business of Merck KGaA, Darmstadt, Germany,...
First Shoulder Arthroplasty Surgeries Using Stryker’s Blueprint® Mixed Reality Guidance System Completed at Mayo Clinic in Minnesota and at St. Joseph’s Health Care London in Canada
Blueprint Mixed Reality Guidance System for shoulder arthroplasty offers surgeons a new tool to execute their pre-operative plan using 3D...
Sona Nanotech Announces Director Retirement
Halifax, Nova Scotia--(Newsfile Corp. - January 10, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona")...
St. Pete Medical Group Joins Angel Tree Initiative, Brightening the Holidays for 40 Children and Seniors
St. Pete Medical Group proudly announces its participation in this year's Angel Tree initiative, spreading joy and cheer by supporting...
AMC Health Strengthens Advisory Board with Appointment of Accomplished Business Leader and Payer/Provider Expert Ken Provencher
Provencher brings a broad set of business management, health policy, leadership and experience to AMC Health.NEW YORK, NY / ACCESSWIRE...
Clearwater Medical Group Joins Forces With the Salvation Army Angel Tree Program, Supporting 40 Angels This Holiday Season
CLEARWATER, FL / ACCESSWIRE / January 10, 2024 / Clearwater Medical Group is proud to announce its collaboration with the...
Angle PLC Announces Standard Form for Notification of Major Holdings
GUILDFORD, SURREY / ACCESSWIRE / January 10, 2024 / ANGLE plc:TR-1: Standard form for notification of major holdings:NOTIFICATION OF MAJOR...
CORRECTION BY SOURCE: Halberd Corp. Signs Significant Revenue Sharing Agreement with Athena GTX
Correction: The initial release stated Mr. Peter Croden was previously Global President of Upjohn/Pfizer Animal Health Division in Germany. The...
Zomedica Corp. to Host Conference Call on January 17, 2024, at 4:30 p.m. ET to Provide a Business Update, Preliminary 2023 Revenue and Cash Position, and Discuss the Proposed Reverse Stock Split; Provides Notice of Special Virtual-Only Meeting of Shareholders on February 28, 2024
ANN ARBOR, MI / ACCESSWIRE / January 10, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary...
Parexel and Japanese Foundation for Cancer Research Announce Strategic Alliance
Collaboration streamlines patient access to oncology clinical trials; further expands Parexel's Site Alliance Network across Asia/PacificDURHAM, N.C. and TOKYO, Jan. 10,...
AIM ImmunoTech Announces Open Enrollment for Phase 1b/2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca’s Imfinzi® (durvalumab) for the Treatment of Pancreatic Cancer
First enrollment and first subject dosing expected soon at Erasmus Medical Center in Rotterdam, Netherlands Management discusses the announcement and...
Clover Health Provides Business Update and Full-Year 2024 Objectives
FRANKLIN, Tenn., Jan. 10, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”),...
ZyVersa Therapeutics’ CEO, Stephen C. Glover, Featured on Benzinga All Access
WESTON, Fla., Jan. 10, 2024 (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA; “ZyVersa”), a clinical stage specialty biopharmaceutical company...
VYNE Therapeutics Announces Positive Biomarker Data from Successful Phase 1b Trial of VYN201 for the Treatment of Vitiligo
VYN201 demonstrated positive effect on key biomarkers relevant to vitiligo Data supports VYN201’s rapid onset of action and previously announced...
Bionano Announces 2024 Symposium: Four Consecutive Days of OGM Presentations and Live Panel Discussions Across a Wide Range of Research Applications
SAN DIEGO, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced its 2024 Symposium, the quintessential event...
MWG Holdings, Award-Winning Cannabis Company, Achieves Positive Cash Flow in 2023; Plans Expansion in 2024
SACRAMENTO, CA, Jan. 10, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – MWG Holdings Group, Inc. (“MWG Holdings” or “MWG”), owner...